Trial Profile
An Open-label, Phase I study to evaluate the drug-drug interaction of GS-9674 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Mar 2023
Price :
$35
*
At a glance
- Drugs Cilofexor (Primary) ; Atorvastatin; Ciclosporin; Dabigatran etexilate; Gemfibrozil; Midazolam; Pravastatin; Rifampicin; Rosuvastatin; Voriconazole
- Indications Non-alcoholic steatohepatitis
- Focus Pharmacokinetics
- 11 Mar 2023 Results assessing to assess potential drug-drug interactions of cilofexor as a victim and as a perpetrator, published in the Clinical Pharmacokinetics.
- 10 Jul 2017 New trial record